375 related articles for article (PubMed ID: 15134437)
1. Differential effects of substrate on type I and type II PKA holoenzyme dissociation.
Vigil D; Blumenthal DK; Brown S; Taylor SS; Trewhella J
Biochemistry; 2004 May; 43(19):5629-36. PubMed ID: 15134437
[TBL] [Abstract][Full Text] [Related]
2. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.
Yu S; Mei FC; Lee JC; Cheng X
Biochemistry; 2004 Feb; 43(7):1908-20. PubMed ID: 14967031
[TBL] [Abstract][Full Text] [Related]
3. Conformational differences among solution structures of the type Ialpha, IIalpha and IIbeta protein kinase A regulatory subunit homodimers: role of the linker regions.
Vigil D; Blumenthal DK; Heller WT; Brown S; Canaves JM; Taylor SS; Trewhella J
J Mol Biol; 2004 Apr; 337(5):1183-94. PubMed ID: 15046986
[TBL] [Abstract][Full Text] [Related]
4. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL
J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976
[TBL] [Abstract][Full Text] [Related]
5. Cyclic-AMP and pseudosubstrate effects on type-I A-kinase regulatory and catalytic subunit binding kinetics.
Anand G; Taylor SS; Johnson DA
Biochemistry; 2007 Aug; 46(32):9283-91. PubMed ID: 17658893
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of activation of cAMP-dependent protein kinase: in Mucor rouxii the apparent specific activity of the cAMP-activated holoenzyme is different than that of its free catalytic subunit.
Zaremberg V; Donella-Deana A; Moreno S
Arch Biochem Biophys; 2000 Sep; 381(1):74-82. PubMed ID: 11019822
[TBL] [Abstract][Full Text] [Related]
7. Solution scattering reveals large differences in the global structures of type II protein kinase A isoforms.
Vigil D; Blumenthal DK; Taylor SS; Trewhella J
J Mol Biol; 2006 Mar; 357(3):880-9. PubMed ID: 16460759
[TBL] [Abstract][Full Text] [Related]
8. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
Prinz A; Diskar M; Erlbruch A; Herberg FW
Cell Signal; 2006 Oct; 18(10):1616-25. PubMed ID: 16524697
[TBL] [Abstract][Full Text] [Related]
9. The roles of the RIIβ linker and N-terminal cyclic nucleotide-binding domain in determining the unique structures of the type IIβ protein kinase A: a small angle x-ray and neutron scattering study.
Blumenthal DK; Copps J; Smith-Nguyen EV; Zhang P; Heller WT; Taylor SS
J Biol Chem; 2014 Oct; 289(41):28505-12. PubMed ID: 25112875
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for isoform-specific autoregulation of protein kinase A.
Diskar M; Zenn HM; Kaupisch A; Prinz A; Herberg FW
Cell Signal; 2007 Oct; 19(10):2024-34. PubMed ID: 17614255
[TBL] [Abstract][Full Text] [Related]
11. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
[TBL] [Abstract][Full Text] [Related]
12. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
Kim C; Cheng CY; Saldanha SA; Taylor SS
Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
[TBL] [Abstract][Full Text] [Related]
13. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase.
Herberg FW; Taylor SS; Dostmann WR
Biochemistry; 1996 Mar; 35(9):2934-42. PubMed ID: 8608131
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
[TBL] [Abstract][Full Text] [Related]
15. Isoform specific differences in binding of a dual-specificity A-kinase anchoring protein to type I and type II regulatory subunits of PKA.
Burns LL; Canaves JM; Pennypacker JK; Blumenthal DK; Taylor SS
Biochemistry; 2003 May; 42(19):5754-63. PubMed ID: 12741833
[TBL] [Abstract][Full Text] [Related]
16. Dynamic binding of PKA regulatory subunit RI alpha.
Gullingsrud J; Kim C; Taylor SS; McCammon JA
Structure; 2006 Jan; 14(1):141-9. PubMed ID: 16407073
[TBL] [Abstract][Full Text] [Related]
17. Two PKA RIα holoenzyme states define ATP as an isoform-specific orthosteric inhibitor that competes with the allosteric activator, cAMP.
Lu TW; Wu J; Aoto PC; Weng JH; Ahuja LG; Sun N; Cheng CY; Zhang P; Taylor SS
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16347-16356. PubMed ID: 31363049
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of novel PKA holoenzymes in human T lymphocytes.
Orstavik S; Funderud A; Hafte TT; Eikvar S; Jahnsen T; Skålhegg BS
FEBS J; 2005 Apr; 272(7):1559-67. PubMed ID: 15794744
[TBL] [Abstract][Full Text] [Related]
19. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
Nesterova MV; Cho-Chung YS
Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA.
Kim C; Xuong NH; Taylor SS
Science; 2005 Feb; 307(5710):690-6. PubMed ID: 15692043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
